Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro-Reference-Cited by-同舟云学术

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

Published:2008-12-24 Issue:7 Volume:135 Page:933-941
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Darb-Esfahani Silvia,Faggad Areeg,Noske Aurelia,Weichert Wilko,Buckendahl Ann-Christin,Müller Berit,Budczies Jan,Röske Annika,Dietel Manfred,Denkert Carsten

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-008-0529-5.pdf

Reference28 articles.

1. Armengol G, Rojo F, Castellvi J et al (2007) 4E-binding protein 1: a key molecular “funnel factor” in human cancer with clinical implications. Cancer Res 67:7551–7555. doi: 10.1158/0008-5472.CAN-07-0881

2. Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF (2006) Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest. Gynecol Oncol 100:487–494. doi: 10.1016/j.ygyno.2005.08.053

3. Bayascas JR, Alessi DR (2005) Regulation of Akt/PKB Ser473 phosphorylation. Mol Cell 18:143–145. doi: 10.1016/j.molcel.2005.03.020

4. Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S (2006) Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107:1801–1811. doi: 10.1002/cncr.22195

5. Chow LM, Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241:184–196. doi: 10.1016/j.canlet.2005.11.042

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic evidence supporting potential causal roles of EIF4 family in breast cancer: a two-sample randomized Mendelian study;Scientific Reports;2024-08-30

2. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets;Cells;2024-02-27

3. High EIF4EBP1 expression reflects mTOR pathway activity and cancer cell proliferation and is a biomarker for poor breast cancer prognosis;American Journal of Cancer Research;2024

4. The expression and significance of p4E‐BP1/4E‐BP1 in prostate cancer;Journal of Clinical Laboratory Analysis;2022-03-08

5. Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?;Cancers;2021-04-03